We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Hidden Vitamin in Beer May Prevent Obesity

By LabMedica International staff writers
Posted on 18 Jun 2012
A new study suggests that nicotinamide riboside (NR), a molecule found in beer and milk, could indirectly influence the activity of cell metabolism, thus preventing weight gain and diabetes, and improving muscular performance.

Researchers at the Federal Polytechnic School of Lausanne (EPFL; Switzerland) and other institutions conducted a study in mice to evaluate if increasing the supply of NR--a natural nicotinamide adenine dinucleotide (NAD+) precursor--could efficiently increases NAD+ levels in mammalian cells and tissues, increase SIRT1 and SIRT3 activities, prevent the detrimental metabolic effects of high-fat feeding, and enhances mitochondrial function and endurance performance. More...
The researchers succeeded in showing that NR was capable of all of these functions, culminating in enhanced oxidative metabolism and protection against high-fat diet-induced metabolic abnormalities.

Mice on a high-fat diet fed NR over a ten-week period gained significantly less weight (60%) than mice eating the same diet, but without NR supplementation. In addition, none of the NR-treated mice had indications that they were developing diabetes, unlike the untreated mice. The mice fed NR supplements also had better endurance performance and improved energy expenditure compared to those who had not received the vitamins; and no side effects were evident in mice given the NR supplement. The study was published on June 6, 2012, in Cell Metabolism.

“The results indicate that the natural vitamin NR could be used as a nutritional supplement to ameliorate metabolic and age-related disorders characterized by defective mitochondrial function,” concluded lead author Carles Canto, PHD, of the EPFL. “Cells use what they need when they need it, and the rest is set aside without being transformed into any kind of deleterious form.”

The researchers believe that the increase in the NR molecule leads to an improvement in mitochondrial function, which is also believed to play a role in the aging process, and hypothesize that by stimulating mitochondrial with the NR molecule, longevity, as well as other health aspects, will also be improved.

Related Links:

Federal Polytechnic School of Lausanne



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.